A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

April 18, 2023

Primary Completion Date

August 29, 2024

Study Completion Date

August 29, 2024

Conditions
Colorectal CancerColorectal NeoplasmsColorectal AdenocarcinomaColorectal Cancer MetastaticNeoplasm, Colorectal
Interventions
DRUG

Fosifloxuridine Nafalbenamide

Intravenous infusion

DRUG

Leucovorin

Intravenous infusion

DRUG

Irinotecan

Intravenous infusion

BIOLOGICAL

Bevacizumab

Intravenous infusion

DRUG

5-FU

Intravenous infusion

Trial Locations (59)

8035

Hospital Universitari Vall d'Hebrón, Barcelona

8908

Hospital Duran i Reynals, Barcelona

13003

Hôpital Européen Marseille, Marseille

13353

Charité Campus Virchow-Klinikum, Berlin

15706

Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela

19713

Helen F. Graham Cancer Center, Newark

20007

Georgetown University Medical Center, Washington D.C.

20133

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

20162

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan

21079

Centre Georges-François Leclerc, Dijon

24008

Hospital de León, León

25000

Centre Hospitalier Régional et Universitaire de Besançon - Hôpital Jean-Minjoz, Besançon

25198

Hospital Universitari Arnau de Vilanova, Lleida

28007

Hospital General Universitario Gregorio Marañón, Madrid

28033

MD Anderson Cancer Center Madrid, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

28222

Hospital Universitario Puerta de Hierro, Majadahonda

28922

Hospital Universitario Fundación Alcorcón, Alcorcón

29010

Hospital Universitario Virgen de la Victoria, Málaga

32610

University of Florida Health Medical Oncology - Davis Cancer Pavilion, Gainesville

33076

Institut Bergonié, Bordeaux

35128

Istituto Oncologico Veneto - IRCCS, Padua

40202

Norton Cancer Institute, Louisville

41013

Hospital Universitario Virgen del Rocío, Seville

44000

Centre Hospitalier UniversitaireNantes - Hôtel Dieu, Nantes

45219

The Christ Hospital Cancer Center, Cincinnati

48121

Ospedale Santa Maria delle Croci di Ravenna, Faenza

48201

Barbara Ann Karmanos Cancer Institute, Detroit

50134

Azienda Ospedaliero Universitaria Careggi, Florence

52242

University of Iowa Hospitals and Clinics, Iowa City

60126

Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona, Ancona

60488

Krankenhaus Nordwest, Frankfurt am Main

67000

Strasbourg Oncology Liberale - Clinique Sainte-Anne, Strasbourg

67214

Cancer Center of Kansas, Wichita

75015

Hôpital Européen Georges-Pompidou, Paris

75246

Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas

75390

University of Texas Southwestern Medical Center, Dallas

75702

USOR - Texas Oncology Northeast Texas, Tyler

80131

Azienda Ospedaliera Universitaria - Università degli Studi della Campania Luigi Vanvitelli, Napoli

81737

München Klinik Neuperlach, München

85100

Azienda Ospedaliera Regionale San Carlo, Potenza

86000

Centre Hospitalier Universitaire de Poitiers, Poitiers

89081

Universitätsklinik Ulm - Oberen Eselsberg, Ulm

92150

Hôpital Foch, Suresnes

98034

Fred Hutchinson Cancer Center at Evergreen Health, Kirkland

98684

Northwest Cancer Specialists, P.C. dba Compass Oncology - Vancouver Cancer Center, Vancouver

02118

Boston Medical Center, Boston

01655

University of Massachusetts Worcester, Worcester

07960

Morristown Medical Center, Morristown

08916

Institut Català d'Oncologia - ICO Badalona - Hospital Universitari Germans Trias i Pujol, Badalona

08041

Hospital de la Santa Creu i Sant Pau, Barcelona

RM7 OAG

Queen's Hospital, Romford

NW1 2PG

University College London Hospitals NHS Foundation Trust, London

NW3 2QG

Royal Free London NHS Foundation Trust, London

SE1 9RT

Guy's and Saint Thomas' NHS Foundation Trust, London

M20 4BX

The Christie NHS Foundation Trust, Manchester

HA6 2RN

Mount Vernon Cancer Centre - East and North Hertfordshire NHS Trust, Northwood

CF14 2TL

Velindre University NHS Trust, Cardiff

G51 4TF

NHS Greater Glasgow and Clyde, Glasgow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

NuCana plc

OTHER

NCT05678257 - A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer | Biotech Hunter | Biotech Hunter